- Annual Report & Financial Statements - 31 Dec 2023
- Response to Share Price Movement
- Positive Results: Midkine mRNA and STAT-6 siRNA
- Operations Update
- Change of Auditor
- Significant Mesodermal Killer Cell Milestone
- Interim Results to 30 June 2023
- Investor Presentation via Investor Meet Company
- Expansion of Patent Portfolio
- Development of New Novel siRNA Therapeutics
More ▼
Key statistics
On Friday, Roquefort Therapeutics PLC (ROQ:LSE) closed at 4.25, 10.39% above the 52 week low of 3.85 set on Apr 05, 2024.
52-week range
Open | 4.25 |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 4.25 |
Average volume | 85.20k |
---|---|
Shares outstanding | 129.15m |
Free float | 35.23m |
P/E (TTM) | -- |
Market cap | 5.49m GBP |
EPS (TTM) | -- |
Data delayed at least 20 minutes, as of May 17 2024 10:20 BST.
More ▼